US Patent Issued to REGENECORE BIOTECH on May 26 for "Humanized anti-il-4RAlpha single domain antibody and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,512, issued on May 26, was assigned to REGENECORE BIOTECH Co. LTD (Jiangsu, China).

"Humanized anti-il-4RAlpha single domain antibody and application thereof" was invented by Zhipeng Su (Jiangsu, China), Yun Zhang (Jiangsu, China), Jinguo Meng (Jiangsu, China), Lefei Wang (Jiangsu, China) and Yao Yao (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a humanized anti-IL-4RAlpha single domain antibody. The antibody has complementarity determining regions and humanized and modified framework regions."

The patent was filed on Feb. 24, 2021, under Application No. 18/001,934.

*For further information, including images, charts and...